In this month’s Kieger AG’s Chart of the Month, we focus on the impressive success of Moderna, BioNTech SE/Pfizer and their partners in increasing the production capacity of their COVID-19 mRNA vaccines. Since the initial announcement of 1bn doses for 2021 in July 2020, Moderna and BioNTech/Pfizer have jointly increased capacity by 300% to 4bn for 2021 in just 10/11 months. For 2022, doses have been increased to 6bn from the 1.2bn announced in January.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.